NCT01688791View on ClinicalTrials.gov

A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)

PHASE1TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Advanced Cancer
Interventions
DRUG

Vintafolide

DRUG

Carboplatin

DRUG

Paclitaxel

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01688791 - A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) | Biotech Hunter | Biotech Hunter